JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266019

Human RRP36 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

RRP36 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 19 bp deletion in exon 1 and 1 bp insertion in exon 1. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.

View Alternative Names

RRP36_HUMAN, Ribosomal RNA processing protein 36 homolog

2 Images
Sanger Sequencing - Human RRP36 knockout HeLa cell line (AB266019)
  • Sanger seq

Unknown

Sanger Sequencing - Human RRP36 knockout HeLa cell line (AB266019)

Allele-2 : 1 bp insertion in exon 1.

Sanger Sequencing - Human RRP36 knockout HeLa cell line (AB266019)
  • Sanger seq

Unknown

Sanger Sequencing - Human RRP36 knockout HeLa cell line (AB266019)

Allele-1 : 19 bp deletion in exon 1.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 19 bp deletion in exon 1 and 1 bp insertion in exon 1

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266019-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB266019-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266019 Human RRP36 knockout HeLa cell line", "number":"AB266019-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266019-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266019 Human RRP36 knockout HeLa cell line", "number":"AB266019-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB266019-CMP02" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266019-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266019 Human RRP36 knockout HeLa cell line", "number":"AB266019-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266019-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266019 Human RRP36 knockout HeLa cell line", "number":"AB266019-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
RRP36
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

RRP36 also known as RRP36 homolog is a protein involved in ribosome biogenesis. It has a molecular mass of approximately 33 kDa. This protein is expressed chiefly in the nucleolus of eukaryotic cells. It plays an important mechanical role in the early stages of processing of precursor rRNA. RRP36 is essential for the maturation of the 90S pre-ribosome an important step in ribosome synthesis.
Biological function summary

The RRP36 protein functions as part of the small subunit (SSU) processome a large ribonucleoprotein complex. This complex plays a significant role in the early cleavage steps of pre-rRNA necessary for forming functional ribosomes. By contributing to pre-rRNA processing RRP36 aids in the efficient production of ribosomal RNA a core component of ribosomes. This precise processing is required for ribosome assembly and cellular protein synthesis.

Pathways

RRP36 integrates into the nucleolar small subunit processome-related pathway influential in ribosome biogenesis. This pathway involves many proteins including UTP4 and UTP15 which closely associate with RRP36 in the SSU processome. The successful operation of this pathway is critical for linking ribosome production to overall cellular growth proliferation and metabolism.

RRP36 shows a connection with disorders resulting from defects in ribosome biogenesis. Impaired ribosome production can contribute to ribosomopathies which include diseases such as Diamond-Blackfan anemia. In this context RRP36 operates alongside other ribosomal biogenesis-related proteins such as UTP18 emphasizing its role in normal cellular functioning and the consequences arising from its dysregulation.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com